NIH supports research and career development for clinician-investigators who completed the StARR R38 program and are entering clinical fellowships or early faculty roles; clinical trials are not allowed.
Funder: National Institutes of Health
Due Dates: November 9, 2026 (Application) | October 13, 2027 (Application) | October 13, 2028 (Application)
Funding Amounts: $10,804,000 estimated program funding; individual support for 12–24 months includes salary, research, and travel funds
Summary: Supports StARR R38 clinician-investigators pursuing mentored research and career development during clinical fellowships or early faculty appointments.
Key Information: Limited to StARR R38 participants completing 12–24 months of research; U.S. citizenship, national status, or permanent residence required by award.
The StARRTS K38 program supports clinician-investigators who successfully complete the Stimulating Access to Research in Residency (StARR) R38 program and continue into clinical fellowships or early career faculty appointments. NIH’s National Heart, Lung, and Blood Institute (NHLBI), National Institute of Allergy and Infectious Diseases (NIAID), and National Cancer Institute (NCI) participate. The goal is to retain these investigators and accelerate their transition toward independent research careers through additional mentored basic, clinical, or translational research.
Transition Scholars may continue with the same mentor, department, or institution, or move to a new setting. Research must align with participating institutes’ missions. Candidates cannot lead an independent clinical trial, clinical trial feasibility study, or ancillary clinical trial, but may gain experience in a trial led by a mentor or co-mentor.